In July, a division bench of the Supreme Court directed the Kerala government, the Union ministry of Ayush (Ayurveda, Yoga, and Naturopathy, Unani, Siddha and Homoeopathy) and the Central Council for Research in Homoeopathy, a research organisation funded by the ministry, to respond to a petition filed by a Kerala doctor questioning the large-scale distribution of the homoeopathic medicine Arsenicum album in the state during the covid-19 pandemic.
It was a small institutional win in an ongoing war that is usually fought on the slippery battleground of social media-its wins and losses measured in hesitant individual acknowledgements of doubt about the efficacy of traditional medical systems, or in the number of death threats received by science communicators on any given day.
While delivering the notice to respond to the government bodies, one of the judges on the division bench, Justice Aniruddha Bose, noted that he also "sometimes takes such medicines", but contradicted the Union ministry's stand on the issue that it is harmless, saying it could be poisonous depending on the "level of dilution".
Arsenicum album is a peculiar medicine in homoeopathy's cabinet-if prepared in the classical way, the final product would contain exactly zero molecules of arsenic, making it about as effective as tap water; but if prepared more, let's say, enthusiastically, it could end up poisoning people as the active ingredient is, indeed, the known poison arsenic.
This story is from the {{IssueName}} edition of {{MagazineName}}.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the {{IssueName}} edition of {{MagazineName}}.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
India in economic sweet spot, inflation to moderate: Moody's
India's economy is in a sweet spot and its inflation is expected to moderate despite a temporary spurt, Moody's said, projecting optimism about the country's growth prospects despite recent underwhelming data.
Incentive engine to drive modern ships
Subsidies for green, high-tech ships under ₹18,000 cr policy
Cement firms wage war on costs as competition soars
India's cement makers who once flexed their pricing muscles are caught in a bruising price war, eroding margins at a time of rising demand.
Saudi Arabia doesn’t have enough money for its futuristic city
The giant futuristic planned city of Neom is proving a headache for Saudi Arabia. Costs are up, schedules are delayed, and in recent days the world’s largest construction project replaced its chief executive of six years.
EV adoption is a marathon, not a sprint: Audi India
The slowdown in electric vehicle (EV) sales is temporary, and the industry will grow over time, Audi India head Balbir Singh Dhillon said, pointing to the need for extensive charging networks and supportive government policies.
India's trade gap with China soars in Apr-Oct
The country's green transition increases reliance on Chinese imports
14 nations eye India's generic drug model
Countries will specify their requirements, with HLL and MEA coordinating with them for the pharma exports
India urges $1.3 tn annual climate grant
Intervening on behalf of like-minded developing countries (LMDCs), India said that developed countries need to commit to provide and mobilise at least $1.3 trillion every year in the New Collective Quantified Goal (NCQG) till 2030.
Over 600 mn cyberattacks daily, AI can secure devices
Microsoft is developing a password-free authentication process to eliminate the risk of breaches
Small businesses ramping up cybersecurity, thanks to AI
Rising AI adoption is helping cybersecurity providers hike their marketable base in India